Literature DB >> 23096495

Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer.

Izabela Laczmanska1, Pawel Karpinski, Marek Bebenek, Tomasz Sedziak, David Ramsey, Elzbieta Szmida, Maria M Sasiadek.   

Abstract

The activity of phosphatases could be influenced by genetic, as well as epigenetic alterations. In our study, we have investigated the methylation status of four PTPRs: PTPRM, PTPRT, PTPRR and PTPRZ1, which were pre-selected using microarray techniques as being alternatively methylated in sporadic colorectal cancer (CRC). The analyses were carried out on 131 surgical specimens obtained from sporadic CRC patients. The methylation status of the four genes was examined using methyl specific PCR (MSP). The analysis of promoter methylation using an Illumina 27K microarray revealed four protein tyrosine phosphatases PTPRM, PTPRT, PTPRR and PTPRZ1 as being hypermethylated with β-value ≥0.2 and P≤0.05. Subsequent analysis using MSP confirmed these observations-the frequency of promoter methylation was significantly higher in tumor cells compared with matched normal tissue for each of the analyzed genes. There was no association observed between the methylation status of PTPRs and either CIMP, K-ras (codon 12) and BRAF (exon 15, V600E) mutations or tumor localization (proximal/distal). The results of our study show a statistically significant difference between promoter methylation in cancerous and healthy tissue. This result supports the hypothesis that the PTPR family has an important role in the etiology of CRC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23096495     DOI: 10.1038/jhg.2012.119

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  17 in total

1.  Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Enping Xu; Jian Gu; Ernest T Hawk; Kenneth K Wang; Maode Lai; Maosheng Huang; Jaffer Ajani; Xifeng Wu
Journal:  Carcinogenesis       Date:  2013-08-29       Impact factor: 4.944

2.  Identification of PTPRR and JAG1 as key genes in castration-resistant prostate cancer by integrated bioinformatics methods.

Authors:  Ji-Li Wang; Yan Wang; Guo-Ping Ren
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

3.  PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapies.

Authors:  Malabika Sen; Audrey Kindsfather; Ludmila Danilova; Feng Zhang; Raffaele Colombo; Matthew G LaPorte; Brenda F Kurland; Donna M Huryn; Peter Wipf; James G Herman
Journal:  Epigenetics       Date:  2019-10-13       Impact factor: 4.528

4.  Customized Array Comparative Genomic Hybridization Analysis of 25 Phosphatase-encoding Genes in Colorectal Cancer Tissues.

Authors:  Izabela Laczmanska; Pawel Skiba; Pawel Karpinski; Marek Bebenek; Maria M Sasiadek
Journal:  Cancer Genomics Proteomics       Date:  2017-01-02       Impact factor: 4.069

5.  Circular RNA expression and circPTPRM promotes proliferation and migration in hepatocellular carcinoma.

Authors:  Zhun Luo; Xuelan Mao; Wei Cui
Journal:  Med Oncol       Date:  2019-09-07       Impact factor: 3.064

6.  PTPN12 inhibits oral squamous epithelial carcinoma cell proliferation and invasion and can be used as a prognostic marker.

Authors:  Zhe Su; Hua Tian; Hong-quan Song; Rui Zhang; An-mei Deng; Hong-wen Liu
Journal:  Med Oncol       Date:  2013-06-04       Impact factor: 3.064

Review 7.  Integration of genome scale data for identifying new players in colorectal cancer.

Authors:  Viktorija Sokolova; Elisabetta Crippa; Manuela Gariboldi
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

Review 8.  Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysis.

Authors:  Sonya E L Craig; Susann M Brady-Kalnay
Journal:  Semin Cell Dev Biol       Date:  2014-09-16       Impact factor: 7.727

Review 9.  Receptor-type protein tyrosine phosphatases in cancer.

Authors:  Yu Du; Jennifer R Grandis
Journal:  Chin J Cancer       Date:  2014-10-17

10.  Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer.

Authors:  Elzbieta Szmida; Pawel Karpiński; Przemyslaw Leszczynski; Tomasz Sedziak; Wojciech Kielan; Paweł Ostasiewicz; Maria M Sasiadek
Journal:  J Appl Genet       Date:  2014-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.